Iq Capital Fund Iv C Lp investment portfolio

IMPERAGEN LIMITED is a Techbio company that accelerates enzyme engineering through its Digital Enzyme Evolution™ technology, which unifies AI-led protein design with novel biotechnology and laboratory automation to create high-performance enzymes. They target diverse markets including pharmaceutical manufacturing, life sciences, sustainable fine chemical production, and industrial applications, developing novel enzyme products for complex drug molecules, laboratory tools, enzyme replacement therapies, and drug delivery systems.